Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass. It is also developing OvaMDx, a multi-marker test that combines serum proteins, clinical data, and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass; EndoCheck, a protein biomarker designed to identify ovarian endometriomas; and EndoMDx for the identification of endometriosis. The company also operates Aspira Labs, a laboratory that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. It has a research agreement with Harvard's Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University of Lodz for the generation of a multi-omic, non-invasive diagnostic aid to identify endometriosis based on circulating miRNAs and proteins; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas. more
Time Frame | AWH | Sector | S&P500 |
---|---|---|---|
1-Week Return | -15.11% | -1.66% | 0.16% |
1-Month Return | -15.02% | -3.08% | 1% |
3-Month Return | -22.13% | -6.66% | 10.69% |
6-Month Return | -64.56% | -1.54% | 12.9% |
1-Year Return | -77.19% | 8.85% | 30.94% |
3-Year Return | -97.43% | 7.9% | 29.66% |
5-Year Return | -93.6% | 45.12% | 92.82% |
10-Year Return | -95.98% | 104.55% | 193.59% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 4.54M | 4.65M | 6.81M | 8.18M | 9.15M | [{"date":"2019-12-31","value":49.57,"profit":true},{"date":"2020-12-31","value":50.81,"profit":true},{"date":"2021-12-31","value":74.42,"profit":true},{"date":"2022-12-31","value":89.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 3.34M | 3.42M | 3.75M | 3.87M | 3.89M | [{"date":"2019-12-31","value":85.89,"profit":true},{"date":"2020-12-31","value":87.74,"profit":true},{"date":"2021-12-31","value":96.35,"profit":true},{"date":"2022-12-31","value":99.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 1.20M | 1.24M | 3.06M | 4.32M | 5.26M | [{"date":"2019-12-31","value":22.71,"profit":true},{"date":"2020-12-31","value":23.49,"profit":true},{"date":"2021-12-31","value":58.19,"profit":true},{"date":"2022-12-31","value":82.08,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 26.33% | 26.57% | 44.95% | 52.77% | 57.48% | [{"date":"2019-12-31","value":45.81,"profit":true},{"date":"2020-12-31","value":46.23,"profit":true},{"date":"2021-12-31","value":78.2,"profit":true},{"date":"2022-12-31","value":91.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 16.47M | 19.22M | 35.66M | 37.08M | 24.11M | [{"date":"2019-12-31","value":44.42,"profit":true},{"date":"2020-12-31","value":51.82,"profit":true},{"date":"2021-12-31","value":96.15,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":65.03,"profit":true}] |
Operating Income | (15.28M) | (17.98M) | (32.59M) | (32.77M) | (18.85M) | [{"date":"2019-12-31","value":-1527800000,"profit":false},{"date":"2020-12-31","value":-1798100000,"profit":false},{"date":"2021-12-31","value":-3259500000,"profit":false},{"date":"2022-12-31","value":-3276500000,"profit":false},{"date":"2023-12-31","value":-1885200000,"profit":false}] |
Total Non-Operating Income/Expense | 100.00K | 86.00K | 885.00K | 5.61M | 2.23M | [{"date":"2019-12-31","value":1.78,"profit":true},{"date":"2020-12-31","value":1.53,"profit":true},{"date":"2021-12-31","value":15.77,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":39.83,"profit":true}] |
Pre-Tax Income | (15.24M) | (17.91M) | (31.66M) | (27.17M) | (16.69M) | [{"date":"2019-12-31","value":-1523700000,"profit":false},{"date":"2020-12-31","value":-1790500000,"profit":false},{"date":"2021-12-31","value":-3166200000,"profit":false},{"date":"2022-12-31","value":-2717000000,"profit":false},{"date":"2023-12-31","value":-1669000000,"profit":false}] |
Income Taxes | (392.00K) | (275.00K) | 48.00K | (5.59M) | (5.59M) | [{"date":"2019-12-31","value":-816.67,"profit":false},{"date":"2020-12-31","value":-572.92,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-11656.25,"profit":false},{"date":"2023-12-31","value":-11656.25,"profit":false}] |
Income After Taxes | (14.85M) | (17.63M) | (31.71M) | (21.57M) | (11.10M) | [{"date":"2019-12-31","value":-1484500000,"profit":false},{"date":"2020-12-31","value":-1763000000,"profit":false},{"date":"2021-12-31","value":-3171000000,"profit":false},{"date":"2022-12-31","value":-2157500000,"profit":false},{"date":"2023-12-31","value":-1109500000,"profit":false}] |
Income From Continuous Operations | (15.24M) | (17.91M) | (31.66M) | (27.17M) | (15.48M) | [{"date":"2019-12-31","value":-1523700000,"profit":false},{"date":"2020-12-31","value":-1790500000,"profit":false},{"date":"2021-12-31","value":-3166200000,"profit":false},{"date":"2022-12-31","value":-2717000000,"profit":false},{"date":"2023-12-31","value":-1547700000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (14.85M) | (17.63M) | (31.71M) | (21.57M) | (16.69M) | [{"date":"2019-12-31","value":-1484500000,"profit":false},{"date":"2020-12-31","value":-1763000000,"profit":false},{"date":"2021-12-31","value":-3171000000,"profit":false},{"date":"2022-12-31","value":-2157500000,"profit":false},{"date":"2023-12-31","value":-1669000000,"profit":false}] |
EPS (Diluted) | (0.19) | (0.18) | (0.28) | (0.27) | (12.01) | [{"date":"2019-12-31","value":-19,"profit":false},{"date":"2020-12-31","value":-17.8,"profit":false},{"date":"2021-12-31","value":-28,"profit":false},{"date":"2022-12-31","value":-27,"profit":false},{"date":"2023-12-31","value":-1201,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
AWH | |
---|---|
Cash Ratio | 0.39 |
Current Ratio | 0.75 |
Quick Ratio | 0.70 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
AWH | |
---|---|
ROA (LTM) | -185.71% |
ROE (LTM) | -723.45% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
AWH | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.53 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.53 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
AWH | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1.36 |
P/B | 5.02 |
Price/FCF | NM |
EV/R | 1.40 |
EV/Ebitda | NM |
PEG | NM |
Aspira Womens Health Inc (AWH) share price today is $0.742
Yes, Indians can buy shares of Aspira Womens Health Inc (AWH) on Vested. To buy Aspira Womens Health Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AWH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Aspira Womens Health Inc (AWH) via the Vested app. You can start investing in Aspira Womens Health Inc (AWH) with a minimum investment of $1.
You can invest in shares of Aspira Womens Health Inc (AWH) via Vested in three simple steps:
The 52-week high price of Aspira Womens Health Inc (AWH) is $5.65. The 52-week low price of Aspira Womens Health Inc (AWH) is $0.67.
The price-to-earnings (P/E) ratio of Aspira Womens Health Inc (AWH) is
The price-to-book (P/B) ratio of Aspira Womens Health Inc (AWH) is 5.02
The dividend yield of Aspira Womens Health Inc (AWH) is 0.00%
The market capitalization of Aspira Womens Health Inc (AWH) is $12.17M
The stock symbol (or ticker) of Aspira Womens Health Inc is AWH